INFLUENCE OF LIVER FIBROSIS ON LIPID METABOLISM IN PATIENTS WITH ARTERIAL HYPERTENSION AND NON-ALCOHOLIC FATTY LIVER DISEASE

Karina Antyukh,Elena Grigorenko,Natalya Mitkovskaya
DOI: https://doi.org/10.1097/01.hjh.0001020588.94310.32
IF: 4.9
2024-05-01
Journal of Hypertension
Abstract:Objective: To study the effect of liver fibrosis on lipid metabolism in patients with arterial hypertension (AH) and non-alcoholic fatty liver disease (NAFLD). Design and method: A cross-sectional comparative single-center study was conducted, which involved 72 patients of working age (age 25-59 years) with stage I-II AH and NAFLD. The patients were divided into two groups depending on the presence/absence of liver fibrosis: group 1 – patients with hypertension, NAFLD+liver fibrosis (n=34), average age 47.1±8.9 years and group 2 – patients with hypertension, NAFLD without liver fibrosis (n=38), average age 48.6±8.5 years. To analyze lipid metabolism, a detailed lipid profile was performed to determine the content of total cholesterol (TC), triglycerides (TG), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and atherogenic coefficient (AC). All patients underwent abdominal ultrasound and liver elastography to determine the degree of fibrosis according to the METAVIR scale. Statistical analysis of the obtained data was carried out using the statistical program package SPSS 27.0 (IBM, USA). Differences were considered statistically significant at p<0.05. Results: When studying lipid metabolism, it was shown that the group average values of TC (5.90±0.90 mmol/l vs. 5.60±0.94 mmol/l, p<0.05), LDL-C (4.07±0.82 mmol/l vs. 3.68±0.82 mmol/l, p<0.05), TG (1.75 [1.33-2.55] mmol/l vs. 1.48 [1.17- 2.4] mmol/l, p<0.05), KA (4.36 ± 1.36 vs. 3.82 ± 0.95, p 0.05) in the compared groups there were significant differences not installed. Conclusions: The results obtained indicate a high prevalence of lipid metabolism disorders among patients of working age with arterial hypertension, non-alcoholic fatty liver disease and developed liver fibrosis, in comparison with persons with high blood pressure syndrome without fibrotic changes in the liver, which indicates an unfavorable pro-atherogenic lipid profile in this category of patients.
peripheral vascular disease
What problem does this paper attempt to address?